R
Robertson Jt
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 3
Citations - 2411
Robertson Jt is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Population & Procarbazine. The author has an hindex of 3, co-authored 3 publications receiving 2369 citations.
Papers
More filters
Journal ArticleDOI
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
Walker,Sylvan B. Green,David P. Byar,Eben Alexander,Batzdorf U,Brooks Wh,William E. Hunt,MacCarty Cs,Mahaley Ms,John Mealey,Owens G,Ransohoff J nd,Robertson Jt,W. R. Shapiro,Smith Kr,Charles B. Wilson,Strike Ta +16 more
TL;DR: It is suggested that it is best to use radiotherapy in the post-surgical treatment of malignant glioma and to continue the search for an effective chemotherapeutic regimen to use in addition to radiotherapy.
Journal ArticleDOI
Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
William R. Shapiro,S. B. Green,P. C. Burger,Mahaley Ms,Selker Rg,VanGilder Jc,Robertson Jt,J. Ransohoff,J. Mealey,Strike Ta +9 more
TL;DR: Within 3 weeks of definitive surgery, 571 adult patients with histologically confirmed, supratentorial malignant gliomas were randomly assigned to receive one of three chemotherapy regimens: BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) alone,BCNU plus hydroxyurea alternating with procarbazine plus VM-26 (epipodophyllotoxin).
Journal Article
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
Sylvan B. Green,David P. Byar,Walker,Pistenmaa Da,Eben Alexander,Batzdorf U,Brooks Wh,William E. Hunt,John Mealey,Odom Gl,Paoletti P,Ransohoff J nd,Robertson Jt,Selker Rg,W. R. Shapiro,Smith Kr,Charles B. Wilson,Strike Ta +17 more
TL;DR: It is indicated that BCNU and procarbazine are moderately useful agents in conjunction with radiotherapy for patients with malignant glioma and future protocols may allow use of corticosteroids in conventional dosages for treating cerebral edema and controlling symptoms.